6-K - Alterity Therapeutics Limited | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Alterity Therapeutics Limited announced a proposed issue of 150,000,000 options as payment for services rendered to Lawrence Gozlan and Julian Babarczy, with an exercise price of A$0.02 and expiry on 26/6/2031, subject to shareholder approval on 27/5/2026. The new class of options will not be quoted on ASX and involves a related party under listing rule 10.11.

Key Takeaways

1Proposed issuance of 150,000,000 options on 26/6/2026

2Options details: exercise price A$0.02, expiry 26/6/2031, underlying ATH ordinary shares

3No cash consideration; AUD equivalent 0.0000001

4Payment for services to Lawrence Gozlan and Julian Babarczy

5Requires shareholder approval on 27/5/2026 under listing rule 7.1

6Party under listing rule 10.11 participating: Yes

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (2)

6-K

REPORT OF FOREIGN PRIVATE ISSUER

99.1

PROPOSED ISSUE OF SECURITIES - ATH